Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06743659 · ClinicalTrials.gov registry record · NA
Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia
A NA study of Familial Hypercholesterolaemia, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 450
- Enrollment target
- 1
- Study location
NCT06743659 is a NA study of Familial Hypercholesterolaemia that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 450 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06743659, a NA study of Familial Hypercholesterolaemia, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 450 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if a computer alert can aid clinicians in identifying patients with a genetic type of high cholesterol, called Familial Hypercholesterolemia. The main question it aims to answer is whether the computer alert increases recognition of this high cholesterol disorder.
Conditions Studied
Interventions
- DEVICE Alert-based computerized decision support
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06743659
The ClinicalTrials.gov registry entry for NCT06743659 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Familial Hypercholesterolaemia appearing as the primary indexed condition, and to 1 intervention - of which Alert-based computerized decision support is the first listed.
NCT06743659 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06743659 about?
NCT06743659 is a clinical study titled "Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia". The goal of this clinical trial is to learn if a computer alert can aid clinicians in identifying patients with a genetic type of high cholesterol, called Familial Hypercholesterolemia. The main question it aims to answer is whether the computer alert increases recognition of this high cholesterol d...
What is the current status of trial NCT06743659?
This trial is currently recruiting. It is a NA study. The enrollment target is 450 participants. The study started on 2025-04-01. Estimated completion is 2027-12-31.
What conditions does trial NCT06743659 study?
This clinical trial studies the following conditions: Familial Hypercholesterolaemia.
What interventions are being tested in trial NCT06743659?
The interventions under investigation include: Alert-based computerized decision support (DEVICE).
Who is sponsoring clinical trial NCT06743659?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06743659 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Familial Hypercholesterolaemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.